atherogenic

Also found in: Thesaurus, Medical, Encyclopedia, Wikipedia.

ath·er·o·gen·e·sis

(ăth′ər-ō-jĕn′ĭ-sĭs)

Formation of atheromatous deposits, especially on the innermost layer of arterial walls.

ath′er·o·gen′ic (-jĕn′ĭk) adj.

ath′er·o·gen·i′ci·ty (-jə-nĭs′ĭ-tē) n.

American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.

atherogenic

(ˌæθərəʊˈdʒɛnɪk)

adj

(Pathology) causing atheroma

ˌatheroˈgenesis n

Collins English Dictionary – Complete and Unabridged, 12th Edition 2014 © HarperCollins Publishers 1991, 1994, 1998, 2000, 2003, 2006, 2007, 2009, 2011, 2014

ath•er•o•gen•ic

(ˌæθ ə roʊˈdʒɛn ɪk)

adj.

capable of producing atheromatous plaques in arteries.

[1950–55]

References in periodicals archive ?

The plasma atherogenic index (PAI) emerged as a valuable marker in determining the risk of CV diseases [3].

The Clinical Importance of the Plasma Atherogenic Index, Other Lipid Indexes, and Urinary Sodium and Potassium Excretion in Patients with Stroke

We need to advise the public to avoid atherogenic diet, set targets for blood pressure and blood glucose.

Obesity itself is a risk factor for Diabetes and Hypertension - Prof. Ahmad Bilal

Newly presented data provide further detail on the trial endpoints, highlighting the changes to LDL-C, atherogenic proteins, and other liver parameters.

Viking Therapeutics says VK2809 study achieves primary, secondary endpoints

M2 PHARMA-May 10, 2018-The Medicines Company Data Show Inclisiran Reduces Subtypes of Atherogenic Lipoproteins

The Medicines Company Data Show Inclisiran Reduces Subtypes of Atherogenic Lipoproteins

The atherogenic indices were calculated as follows:

Preclinical Lipid Profile Studies of a Classical Ayurvedic Preparation, Siddha Makardhwaja (SMD), after Chronic Administration to Male Sprague-Dawley Rats

The first method was to calculate the atherogenic index of the plasma (AIP).

Shift Work and the Risk of Cardiovascular Diseases and Metabolic Syndrome Among Jordanian Employees

With the emergence of the concept of 'atherogenic dyslipidemia' and 'residual risk' non-HDL-c have been proven to perform better in terms of risk prediction for CVD.8,9 Moreover, some evidence is also available where correlation between LDL-c and non-HDL-c was observed to be less in MS.10 Lastly, non-HDL-c, unlike TG and LDL-c, needs prior fasting while non-HDL-c has been recommended in non-fasting status thus implying its possible application more feasible and cost-effective.11

Status of non-HDL-cholesterol and LDL-cholesterol among subjects with and without metabolic syndrome

Despite availability of effective glycemic control regimes, diabetes mellitus still remains associated with the risk of developing coronary heart diseases.1-3 Large number of clinical and research evidences indicate that both diabetic mellitus and insulin resistance lead to endothelial dysfunctions which in turn increase the risk of atherogenic function of the vascular endothelium.1

Nonfasting Apo-lipoprotein B and Triglyceride levels as a predictor of coronary heart disease in Type II diabetic patients

The purpose of this study was to evaluate the beneficial effects of NAC on the lipid profile and atherogenic index in rats with experimentally induced T1DM.

Effect of N-Acetylcysteine on Dyslipidemia and Carbohydrate Metabolism in STZ-Induced Diabetic Rats

pylori infection, although results of the current study were not to the extent of justifying the atherogenic effects of H.

Effect of Helicobacter pylori Infection on Serum Lipid Profile

The atherogenic index of plasma (AIP) is a critical index that can be used as a stand-alone index for cardiac risk estimation [8].

Understanding the Relationship between Atherogenic Index of Plasma and Cardiovascular Disease Risk Factors among Staff of an University in Malaysia

Full browser ?

CITE

Site: Follow: Share:

Open / Close